Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market By Product (Robotic Systems, Instruments, Accessories), By End-User (Hospitals, Cath Labs, Other End-Users), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2031

Percutaneous Coronary Intervention (PCI) with robot assistance is a non-surgical approach to implant a stent that reduces the risk of orthopedic injury and operator fatigue. PCI with robot assistance is a medical treatment to treat obstructive coronary artery disease, and it aids an the opening-up of blocked or restricted blood arteries. In comparison to traditional PCI, robot-aided PCI has a higher rate of success and accuracy.

Detailed Segmentation –

The global robot-assisted percutaneous coronary intervention market is segmented on the basis of – Product Type, End-User, and Region. Represented below is a detailed segmental description:

Based on Product Type:

• Robotic Systems
• Instruments
• Accessories

Based on End-User:

• Hospitals
• Cath Labs
• Other End-Users

Based on Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Market Dynamics –

Drivers for the Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market:

One of the primary factors propelling this market’s revenue growth trajectory is the increase in the demand for robotically-assisted procedures, as well as a developing determinant, a surging geriatric population, in conjuction with numerous increasing innovations and technological advancements. These are certain factors that will help augment this target market in the years to come.

Restraints for the Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market:

In developing and underdeveloped economies, an inefficient and unfavorable reimbursement scenario is expected to hamper this market’s further economic expansion. Additionally, the steep expenses associated with robotically-assisted procedures may also lead to further challenge this industry in the years to come. Moreover, a scarcity of skilled specialists are expected to also stifle market expansion prospects.

Opportunities for the Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market:

Increasing awareness levels concerning the importance of healthy living among individuals, the adopation of unhealthy dietary patterns, the increasing demand for minimally invasive surgeries, as well as an exponential spike in medical tourism are important factors that are anticipated to create lucrative opportunities for this market.

Competitive Landscape –

Key players in this market are –

• Stryker Corporation
• Medtronic Plc
• Intuitive Surgical Inc.
• Zimmer Biomet
• Smith+Nephew Plc
• Asensus Surgical US Inc.
• Medrobotics Corporation
• THINK Surgical Inc.
• Auris Health Inc.
• CMR Surgical Ltd.
• Medtech Life Pvt. Ltd.
• Corindus Inc.
• Renishaw plc
• Medical Devices Business Services Inc.
• meerecompany Inc.
• Titan Medical Inc.
• Venus Concept
• Accuray Incorporated
• Stereotaxis Inc.
• KUKA AG
• others

These key industry players are now focusing on mergers, partnerships, acquisitions, product developments, and collaboration strategies, in order to sustain their respective competitive edges.

Key Developments –

Year 2021:

• Eric Durand of the Rouen Medical Training Center in France, Rouen, and Rémi Sabatier of Caen University Hospital in France, completed the first remote robotic-assisted PCI surgery in Europe, spanning 75 miles between the two locations.

For the Vаlеnсеnе Market research study, the following years have been considered to estimate the market size: